Question 1

Does Loring Wolcott & Coolidge Fiduciary Advisors own TEVA stock?

Accepted Answer

No. Loring Wolcott & Coolidge Fiduciary Advisors exited its TEVA (Teva Pharmaceutical Industries) position in Q3 2023. Its Q2 2023 13F listed 300 shares worth $2,259.

Question 2

How many shares of TEVA does Loring Wolcott & Coolidge Fiduciary Advisors own?

Accepted Answer

None since Q3 2023, when Loring Wolcott & Coolidge Fiduciary Advisors exited the position. Its Q2 2023 13F listed 300 shares worth $2,259.

Question 3

What is Loring Wolcott & Coolidge Fiduciary Advisors' TEVA position worth?

Accepted Answer

Loring Wolcott & Coolidge Fiduciary Advisors' TEVA position was worth $2,259 in its Q2 2023 13F, before the exit in Q3 2023.

Question 4

Is Loring Wolcott & Coolidge Fiduciary Advisors buying or selling TEVA?

Accepted Answer

In Q3 2023, Loring Wolcott & Coolidge Fiduciary Advisors exited its entire TEVA position.

Question 5

When did Loring Wolcott & Coolidge Fiduciary Advisors first buy TEVA?

Accepted Answer

Loring Wolcott & Coolidge Fiduciary Advisors first reported TEVA in its Q1 2023 13F and listed it in 2 quarterly 13F filings.